Presentation is loading. Please wait.

Presentation is loading. Please wait.

Time-courses of plasma IL-6 and HMGB-1 reflect initial severity of clinical presentation but do not predict poor neurologic outcome following subarachnoid.

Similar presentations


Presentation on theme: "Time-courses of plasma IL-6 and HMGB-1 reflect initial severity of clinical presentation but do not predict poor neurologic outcome following subarachnoid."— Presentation transcript:

1 Time-courses of plasma IL-6 and HMGB-1 reflect initial severity of clinical presentation but do not predict poor neurologic outcome following subarachnoid hemorrhage  Heikki Kiiski, Jaakko Långsjö, Jyrki Tenhunen, Marika Ala-Peijari, Heini Huhtala, Mari Hämäläinen, Eeva Moilanen, Juha Öhman, Jukka Peltola  eNeurologicalSci   Volume 6, Pages (March 2017) DOI: /j.ensci Copyright © 2016 The Authors Terms and Conditions

2 Fig. 1 IL6 levels measured within the first 24h after aSAH in relation to the initial clinical presentation. Patients with more severe clinical presentations had significantly higher IL-6 levels (p=0.002). Black circles represent outliers. eNeurologicalSci  2017 6, 55-62DOI: ( /j.ensci ) Copyright © 2016 The Authors Terms and Conditions

3 Fig. 2 IL6 levels measured within the first 24h after aSAH in relation to clinically suspected infection during ICU follow-up. Early IL-6 levels are significantly higher in patients with infection during follow-up (p=0.031). Black circles represent outliers. eNeurologicalSci  2017 6, 55-62DOI: ( /j.ensci ) Copyright © 2016 The Authors Terms and Conditions

4 Fig. 3 IL6 levels measured within the first 24h after aSAH in relation to the severity of aSAH in primary CT. There is a trend towards higher IL-6 levels in patients with more severe CT findings but statistical significance is not reached by a narrow margin (p=0.051). Black circles represent outliers. eNeurologicalSci  2017 6, 55-62DOI: ( /j.ensci ) Copyright © 2016 The Authors Terms and Conditions

5 Fig. 4 IL-6 and HMGB1 levels for patients (n=22) with the ICU follow-up lasting for five days (n=22). Circles represent individual patient values. Values are grouped into favorable and non-favorable neurological outcome. Linear regression shows no significant change between baseline values for IL-6 (mRS 0–2: p-value 0.084, beta −1.048/mRS 3–6: p-value 0.515, beta −0.879) or HMGB1 (mRS 0–2: p-value 0.454, beta 0.183/mRS 3–6: p-value 0.776, beta 0.106) during the follow-up. Outliers are not shown. eNeurologicalSci  2017 6, 55-62DOI: ( /j.ensci ) Copyright © 2016 The Authors Terms and Conditions

6 Fig. 5 Scatter plots displaying the correlation of individual patient values of IL-6 against those of HGMB1 at different time points during the ICU follow-up. Outliers are not shown. eNeurologicalSci  2017 6, 55-62DOI: ( /j.ensci ) Copyright © 2016 The Authors Terms and Conditions


Download ppt "Time-courses of plasma IL-6 and HMGB-1 reflect initial severity of clinical presentation but do not predict poor neurologic outcome following subarachnoid."

Similar presentations


Ads by Google